Multi-source·Jul 22, 2026·2 sources analyzed
FDA advisers are meeting this week on compounded peptide drugs
The FDA's Pharmacy Compounding Advisory Committee meets July 23-24 to weigh whether pharmacies should be allowed to compound seven peptide substances used for claims including wound healing, obesity, insomnia, and migraine.
Image: Modern Action subject: FDA Oversight of Compounded Drugs and Unapproved Wellness Products
Connected public decisions
Follow the issue pages where this story connects to public action.
Contact officials
Act on Compounded drugs and wellness products
See the current decision, choose your position, and send a message through the issue page.
Take action on Compounded drugs and wellness products